Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis
- PMID: 16079166
- PMCID: PMC1798080
- DOI: 10.1136/ard.2005.040659
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis
Abstract
Objective: To investigate the temporal relationship between onset of inflammation (as measured by secretory phospholipase A2 (sPLA2) and C reactive protein (CRP)) and the presence of autoantibodies (IgM rheumatoid factor (IgM RF) and antibodies against citrullinated peptides (anti-CCP)) in the preclinical phase of rheumatoid arthritis (RA).
Methods: For 79 patients with RA who had been blood donors before the onset of disease, a median of 13 serum samples per patient was available. sPLA2 was measured in patient and matched control samples and related to previous CRP, IgM RF, and anti-CCP measurements. The temporal relationship between the increased markers of inflammation and autoantibodies was analysed with time lag analysis.
Results: IgM RF and anti-CCP concentrations were significantly associated (p<0.001) with concentrations of sPLA2, CRP, and the combination of sPLA2 and CRP at the same time point. However, we found no stronger association between the two autoantibody tests and the three inflammation measures 1, 2, and 3 years before or after a time point than for measurements at the same time, in the whole group or in subgroups of IgM RF and anti-CCP positive patients.
Conclusion: Both the acute phase response and autoantibody formation often develop years before the first symptoms of RA occur, and these phenomena are probably closely connected in time.
Conflict of interest statement
Similar articles
-
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.Ann Rheum Dis. 2005 Feb;64(2):299-302. doi: 10.1136/ard.2004.023523. Epub 2004 May 27. Ann Rheum Dis. 2005. PMID: 15166003 Free PMC article.
-
[Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):163-70. Mikrobiyol Bul. 2003. PMID: 14593899 Turkish.
-
Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.Clin Rheumatol. 2007 Feb;26(2):201-4. doi: 10.1007/s10067-006-0275-5. Epub 2006 Mar 30. Clin Rheumatol. 2007. PMID: 16572283
-
The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.Rheumatol Int. 2012 Dec;32(12):3807-12. doi: 10.1007/s00296-011-2260-9. Epub 2011 Dec 21. Rheumatol Int. 2012. PMID: 22187055
-
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.Ann Intern Med. 2007 Jun 5;146(11):797-808. doi: 10.7326/0003-4819-146-11-200706050-00008. Ann Intern Med. 2007. PMID: 17548411 Review.
Cited by
-
Artemisia pallens W. Attenuates Inflammation and Oxidative Stress in Freund's Complete Adjuvant-Induced Rheumatoid Arthritis in Wistar Rats.Diseases. 2024 Sep 29;12(10):230. doi: 10.3390/diseases12100230. Diseases. 2024. PMID: 39452473 Free PMC article.
-
Anti-arthritic activity and phytochemical composition of "Cao Khai" (Aqueous extracts of Coptosapelta flavescens Korth.).Heliyon. 2022 Feb 18;8(2):e08933. doi: 10.1016/j.heliyon.2022.e08933. eCollection 2022 Feb. Heliyon. 2022. PMID: 35243058 Free PMC article.
-
GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease.J Clin Med. 2020 Aug 1;9(8):2472. doi: 10.3390/jcm9082472. J Clin Med. 2020. PMID: 32752190 Free PMC article.
-
Network Pharmacology, Molecular Docking and in vivo-based Analysis on the Effects of the MBZM-N-IBT for Arthritis.Curr Comput Aided Drug Des. 2025;21(2):194-210. doi: 10.2174/0115734099307360240731052835. Curr Comput Aided Drug Des. 2025. PMID: 39108124
-
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.Int J Mol Sci. 2012 Sep 26;13(10):12315-35. doi: 10.3390/ijms131012315. Int J Mol Sci. 2012. PMID: 23202900 Free PMC article. Review.
References
-
- Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991181282–1284. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous